chartexchange

Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference

GlobeNewswire Inc. | Oct 27, 2026 4:01 PM EDT

WALTHAM, Mass. and BOULDER, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc.  (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its participation in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Tuesday, November 10, 2026 at 7:30 a.m. ET.

Read original article